Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diffuse visual field loss and glaucoma

P Asman1, A Heijl

  • 1Department of Ophthalmology, Malmö General Hospital, Sweden.

Acta Ophthalmologica
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simvastatin downregulates adipogenesis in 3T3-L1 preadipocytes and orbital fibroblasts from Graves' ophthalmopathy patients.

Endocrine connections·2019
Same author

Increased TRAb and/or low anti-TPO titers at diagnosis of graves' disease are associated with an increased risk of developing ophthalmopathy after onset.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2014
Same author

Optic disc classification by the Heidelberg Retina Tomograph and by physicians with varying experience of glaucoma.

Eye (London, England)·2011
Same author

Focusing on glaucoma progression and the clinical importance of progression rate measurement: a review.

Eye (London, England)·2010
Same author

The malmo high risk ocular hypertension study.

Journal of glaucoma·2009
Same author

Arcuate cluster analysis in glaucoma perimetry.

Journal of glaucoma·2009
Same journal

En face localization of retinal telangiectatic capillaries using OCT compared with ICG angiography in chronic vascular macular oedema.

Acta ophthalmologica·2026
Same journal

Usher syndrome-related visual impairment in Finland: A 35-year nationwide register-based study (1985-2019).

Acta ophthalmologica·2026
Same journal

Three years of ocular proton therapy in the Netherlands, clinical results.

Acta ophthalmologica·2026
Same journal

Risk factors for acquisition and severity of Acanthamoeba and Fusarium keratitis in contact lens users-A case-control and clinical-epidemiological study, 2009-2020.

Acta ophthalmologica·2026
Same journal

Distinguish polypoidal choroidal vasculopathy through choroidal alterations: A systematic review, meta-analysis and narrative synthesis.

Acta ophthalmologica·2026
Same journal

Ocular blood flow and retinal oxygen saturation measurements in central retinal artery occlusion.

Acta ophthalmologica·2026
See all related articles

Diffuse visual field loss is not an early sign of glaucoma. This study found that general reduction in light sensitivity, without localized loss, is typically caused by other eye conditions, not early glaucoma.

Area of Science:

  • Ophthalmology
  • Optometry
  • Visual Science

Background:

  • Diffuse visual field loss is commonly considered an early indicator of glaucoma.
  • Clinical observations and prior studies suggest this notion may be inaccurate.

Purpose of the Study:

  • To investigate the factors associated with diffuse visual field loss.
  • To determine if diffuse field loss is a reliable early sign of glaucoma.

Main Methods:

  • Retrospective review of 4222 Humphrey 30-2 threshold visual field tests from 1582 eyes of 862 patients with ocular hypertension or glaucoma.
  • Evaluation of field tests using the Glaucoma Hemifield Test (GHT) to identify localized and general sensitivity changes.
  • Analysis of patient records for identified cases of diffuse field loss.

Related Experiment Videos

Main Results:

  • Diffuse visual field loss without localized defects was found in 117 tests (from 69 patients).
  • In the analyzed patient records (60 eyes), causes included media opacities (77%), miotic therapy (77%), end-stage glaucoma (17%), and other non-glaucomatous ocular pathology (3%).
  • Only 2 out of 1582 eyes showed diffuse sensitivity reduction unexplained by non-glaucomatous reasons.

Conclusions:

  • General reduction of differential light sensitivity as an isolated finding is rarely associated with early to moderate glaucoma.
  • Purely diffuse visual field loss is not a characteristic sign of glaucoma.